Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.
Sundström J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, Taveira-Gomes T, Botana M, Birkeland KI, Thuresson M, Jäger L, Sood MM, VanPottelbergh G, Tangri N; CaReMe CKD Investigators. Sundström J, et al. Among authors: vervloet mg. Lancet Reg Health Eur. 2022 Jun 30;20:100438. doi: 10.1016/j.lanepe.2022.100438. eCollection 2022 Sep. Lancet Reg Health Eur. 2022. PMID: 36090671 Free PMC article.
Most exposed: the endothelium in chronic kidney disease.
Vila Cuenca M, Hordijk PL, Vervloet MG. Vila Cuenca M, et al. Among authors: vervloet mg. Nephrol Dial Transplant. 2020 Sep 1;35(9):1478-1487. doi: 10.1093/ndt/gfz055. Nephrol Dial Transplant. 2020. PMID: 31071222 Free PMC article. Review.
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
De Jong MA, Eisenga MF, van Ballegooijen AJ, Beulens JWJ, Vervloet MG, Navis G, Gansevoort RT, Bakker SJL, De Borst MH. De Jong MA, et al. Among authors: vervloet mg. Nephrol Dial Transplant. 2021 Jan 1;36(1):121-128. doi: 10.1093/ndt/gfz266. Nephrol Dial Transplant. 2021. PMID: 32124925 Free PMC article.
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial.
Cherney DZI, Dekkers CCJ, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, Laverman GD, Lim SK, Di Tanna GL, Reich HN, Vervloet MG, Wong MG, Gansevoort RT, Heerspink HJL; DIAMOND investigators. Cherney DZI, et al. Among authors: vervloet mg. Lancet Diabetes Endocrinol. 2020 Jul;8(7):582-593. doi: 10.1016/S2213-8587(20)30162-5. Lancet Diabetes Endocrinol. 2020. PMID: 32559474 Clinical Trial.
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study.
Eveleens Maarse BC, Chesnaye NC, Schouten R, Michels WM, Bos WJW, Szymczak M, Krajewska M, Evans M, Heimburger O, Caskey FJ, Wanner C, Jager KJ, Dekker FW, Meuleman Y; EQUAL Study Investigators. Eveleens Maarse BC, et al. Clin Kidney J. 2021 Dec 16;15(4):786-797. doi: 10.1093/ckj/sfab261. eCollection 2022 Apr. Clin Kidney J. 2021. PMID: 35371440 Free PMC article.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Sen T, Scholtes R, Greasley PJ, Cherney DZI, Dekkers CCJ, Vervloet M, Danser AHJ, Barbour SJ, Karlsson C, Hammarstedt A, Li Q, Laverman GD, Bjornstad P, van Raalte DH, Heerspink HJL. Sen T, et al. Diabetes Obes Metab. 2022 Aug;24(8):1578-1587. doi: 10.1111/dom.14729. Epub 2022 Jun 1. Diabetes Obes Metab. 2022. PMID: 35478433 Free PMC article. Clinical Trial.
Magnesium Administration in Chronic Kidney Disease.
Vermeulen EA, Vervloet MG. Vermeulen EA, et al. Among authors: vervloet mg. Nutrients. 2023 Jan 20;15(3):547. doi: 10.3390/nu15030547. Nutrients. 2023. PMID: 36771254 Free PMC article. Review.
210 results